about
Study of neurontin: titrate to effect, profile of safety (STEPS) trial: a narrative account of a gabapentin seeding trialState Medicaid programs did not make use of prior authorization to promote safer prescribing after rosiglitazone warningPublication of NIH funded trials registered in ClinicalTrials.gov: cross sectional analysisClinical trial registration, reporting, publication and FDAAA compliance: a cross-sectional analysis and ranking of new drugs approved by the FDA in 2012Use of health care services by lower-income and higher-income uninsured adultsRevisiting Essure--Toward Safe and Effective SterilizationGuest authorship and ghostwriting in publications related to rofecoxib: a case study of industry documents from rofecoxib litigationRecent trends in chronic disease, impairment and disability among older adults in the United StatesTrial publication after registration in ClinicalTrials.Gov: a cross-sectional analysisAdherence of pharmaceutical advertisements in medical journals to FDA guidelines and content for safe prescribingInconsistencies among European Union pharmaceutical regulator safety communications: a cross-country comparisonCharacterisation of trials where marketing purposes have been influential in study design: a descriptive studyClinical research data sharing: what an open science world means for researchers involved in evidence synthesisAvailability of Clinical Trial Data From Industry-Sponsored Cardiovascular TrialsPredictors of clinical trial data sharing: exploratory analysis of a cross-sectional surveySea change in open science and data sharing: leadership by industryMoving forward from rhBMP-2: open science and data sharingSharing of clinical trial data among trialists: a cross sectional surveyThe importance of clinical trial data sharing: toward more open sciencePublication and reporting of clinical trial results: cross sectional analysis across academic medical centers.Advanced access scheduling outcomes: a systematic review.Ushering in a new era of open science through data sharing: the wall must come down.US Federal Government Efforts to Improve Clinical Trial Transparency with Expanded Trial Registries and Open Data Sharing.Comparison of two independent systematic reviews of trials of recombinant human bone morphogenetic protein-2 (rhBMP-2): the Yale Open Data Access Medtronic ProjectDevelopment and Validation of an Algorithm to Identify Planned Readmissions From Claims Data.Data Desert for Inferior Vena Caval Filters: Limited Evidence, Supervision, and Research.Racial and ethnic differences in personal cervical cancer screening amongst post-graduate physicians: results from a cross-sectional surveyPooled analysis of rofecoxib placebo-controlled clinical trial data: lessons for postmarket pharmaceutical safety surveillanceSelf-reported and actual beta-blocker prescribing for heart failure patients: physician predictors.For-profit hospital ownership status and use of brachytherapy after breast-conserving surgeryThe relationship between systolic blood pressure on admission and mortality in older patients with heart failure.Physician clinical management strategies and reasoning: a cross-sectional survey using clinical vignettes of eight common medical admissions.Beyond insurance coverage: usual source of care in the treatment of hypertension and hypercholesterolemia. Data from the 2003-2006 National Health and Nutrition Examination Survey.Usual source of care and outcomes following acute myocardial infarction.Postapproval studies of drugs initially approved by the FDA on the basis of limited evidence: systematic review.Recent national trends in readmission rates after heart failure hospitalization.Health care choices and decisions in the United States and CanadaMis-SHAPEing public health policy.Association of Admission to Veterans Affairs Hospitals vs Non-Veterans Affairs Hospitals With Mortality and Readmission Rates Among Older Men Hospitalized With Acute Myocardial Infarction, Heart Failure, or Pneumonia.National assessment of early β-blocker therapy in patients with acute myocardial infarction in China, 2001-2011: The China Patient-centered Evaluative Assessment of Cardiac Events (PEACE)-Retrospective AMI Study.
P50
Q24604806-6F19E940-85C3-403C-B239-A3F4BB0FA90BQ24604853-0A62D513-63FD-4D6F-8902-0A0B3E39A901Q24718169-A3F93143-37E3-403A-ABFF-2550B77A5204Q26777323-BADE43AF-EE36-49F3-9018-0CE93EE5ECA0Q28217417-60736C3D-4AD2-4E3C-9EBC-50829C2E0E08Q28267674-190E80B2-6002-4AA5-9979-AA91F3FCB1E5Q28276588-00F7BE24-2592-4E66-8C36-2631D75457AAQ28391793-45CCB37E-5307-429F-A170-2CD5CD4DD352Q28476002-7C2CB0E4-42AF-45D5-BD47-B005D1AE3C96Q28476593-08395A19-7DD7-4F87-B7A1-25BF3683DD83Q28543959-190BECC1-904A-4C49-8F6B-FEFB22055D02Q28552705-CC225437-5055-4F05-8F54-CBB95D330672Q28595531-E1A5A15D-8094-4EA4-BEB3-93C5277E8140Q28603131-35E1C08E-F9A2-4422-8658-C6537299ABA4Q28654786-B60F7360-F147-4B6B-A31E-044E7B771ABEQ28656418-2B259E04-2253-4B27-AE7E-B1605443B954Q28660290-07AE5A0F-BD90-417E-BDE1-F7FB4E14E2E1Q28710576-9E34DD37-708E-4495-9152-A8B19659939DQ28730765-B0554282-8D5F-424E-8AFE-737917BA256EQ30360244-0C3EC308-E02A-4525-B223-804DBBCF19ACQ30484953-8E7D749D-0264-4AC0-BCF3-54E4AB397804Q30486017-43296524-F93D-47E0-8A0A-2AFAC1A685C1Q30488715-8276FE69-912A-4DA4-B3A1-2C084B722728Q30490905-74D204F5-7BF4-448D-96AA-B20719DD08F6Q30978928-BB2E4D75-941D-4F98-B00A-0F2AE9F1FA39Q31140556-89A04B72-5160-43C1-B937-126208367E4EQ33381389-AC52A058-0FB2-43D8-BB7B-D6187DC776D9Q33516504-F455CCEC-FF5A-4A5C-9D29-B49DF656D597Q33521687-19E881A6-CF51-4394-8411-2C054CDE3D7EQ33561585-FC9601B3-E240-43B2-A238-25630767929FQ33595656-B33ED2E9-519B-42AA-BCA5-E8235BE11061Q33611921-DDD16B1D-711A-48C1-AFCD-E3CBC64CDA3AQ33624538-E0739900-253F-4EDC-BFD9-7F71817B723EQ33633087-8B7F51CF-7816-4C19-9F09-FD91D558C3EFQ33647393-315AAACD-FD2B-47B5-8902-9E2CDA3F8CAAQ33697596-9919E9A3-DF19-4475-8EF2-6DFE3F12FB5FQ33713570-57362F82-6CE9-4676-AAD8-EC7F16BB2318Q33713610-27D2A5B1-6B3E-4CFC-9EF2-33201BF9E82CQ33764507-B81E7FFD-4DF6-4E30-834A-DD2A8898C605Q33764581-B29B7A43-4A94-4D87-9790-27A53471D9BA
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Joseph S. Ross
@ast
Joseph S. Ross
@en
Joseph S. Ross
@es
Joseph S. Ross
@nl
Joseph S. Ross
@sl
جوزيف إس. روس
@ar
type
label
Joseph S. Ross
@ast
Joseph S. Ross
@en
Joseph S. Ross
@es
Joseph S. Ross
@nl
Joseph S. Ross
@sl
جوزيف إس. روس
@ar
altLabel
Joseph Ross
@en
prefLabel
Joseph S. Ross
@ast
Joseph S. Ross
@en
Joseph S. Ross
@es
Joseph S. Ross
@nl
Joseph S. Ross
@sl
جوزيف إس. روس
@ar
P106
P1153
12789607900
P21
P31
P496
0000-0002-9218-3320